Unveiling Novel Insights in Chronic Myeloid Leukemia Cell Lines K562 through in vitro and in silico Approach Targeting of Apoptosis and Oxidative Stress Pathways
1★★ Corresponding author
- 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran, KINGDOM OF SAUDI ARABIA.
CORRESPONDENCE
Hassan H Almasoudi
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran, KINGDOM OF SAUDI ARABIA.
Received: 22-09-2025; Revised: 18-11-2025; Accepted: 01-12-2025.
Volume 60, Issue 1S · pp. s358–s370 · 2026 · DOI: 10.5530/ijper.20263903
ABSTRACT
Introduction: Troxerutin (TR), bioflavanoid derived from rutin posess several biological activity like antioxidant, antinflammatory, antidiabetic and antitumor activity and found to be alternative candidate for cancer therapy. Chronic Myelogenous Leukaemia (CML) is a hematoproliferative disorder caused by uncontrolled myeloid cell division in bone marrow charecterized by Bcr and Abl gene fusion. This study aimed to evaluate the anticancer activity of TR on K562 chronic myeloid leukemia cell line.Materials and Methods: The cytoxocity was assessed by MTT and phase contrast microscopy. DAPI staining was carried out to confirm apoptosis. The antioxidant status was determined by Glutathione (GSH) levels. Molecular docking was carried out to understand the interaction between p53 and TR. Caspase-9 level was quantified by ELISA whereas gene expression of BAX, p53 and Bcl-2 level by qRT-PCR.Results: The cell growth of K562 was reduced in dose dependent manner with rounding and cell shrinkage. Oxidative stress mediated apoptosis was observed by elevated GSH level and nuclear condensation by DAPI. The increased gene expression level of Bax and p53 with decreased level of Bcl-2 was confirmed. Molecular docking analysis depicted binding affinity of TR with p53 confirming its potential role in apoptosis induction.Conclusion: The anticancer activity of troxerutin against K562 cells was induced apoptosis by ROS-mediated oxidative stress and p53-dependent apoptotic pathway supporting therapeutic potential to treat CML.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Almasoudi, H. H. (2026). Unveiling Novel Insights in Chronic Myeloid Leukemia Cell Lines K562 through in vitro and in silico Approach Targeting of Apoptosis and Oxidative Stress Pathways. Indian Journal of Pharmaceutical Education and Research, 60(1S), s358–s370. https://doi.org/10.5530/ijper.20263903